Connect Education Workshop Details
Help
How ER (Estrogen Receptor) & HER2 Status Help Determine Treatment Options for Women Living with Breast Cancer
- Overview of Breast Cancer
- How ER (Estrogen Receptor) and HER2 Status Help Determine Treatment Options
- Current Standard of Care
- New Treatment Options
- Clinical Trials
- Communicating with Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Eric P. Winer, MD Director, Breast Oncology Center, Professor of Medicine, Harvard Medical School, Chief Scientific Advisor, Susan G. Komen for the Cure |
|
Generosa Grana, MD Director, Breast Cancer Program, Cooper Hospital, UMC, Associate Professor of Medicine, University of Medicine & Dentistry of New Jersey, Robert Wood Johnson School of Medicine |
|
Patricia Spicer, MSW Breast Cancer Program Coordinator, CancerCare |
|
American Cancer Society, American Society of Clinical Oncology, Association of Clinicians for the Underserved, Association of Oncology Social Work, Black Women's Health Imperative, Breast Cancer Network of Strength, The Breast Cancer Research Foundation, Breast Cancer Resource Committee/ Rise Sister Rise, Cancer Patient Education Network, Education Network to Advance Cancer Clinical Trials, Intercultural Cancer Council, Linda Creed Breast Cancer Foundation, Living Beyond Breast Cancer, Men Against Breast Cancer, Metastatic Breast Cancer Network, Multinational Association of Supportive Care in Cancer, National Center for Frontier Communities, National Coalition for Cancer Survivorship, Research Advocacy Network, The Wellness Community, The Witness Project, Young Survival Coalition
Supported by an educational grant from sanofi-aventis U.S. LLC.
April 30, 2008








